Drug Policy
Research Interests
Carin Bouchard, PharmD, BCPS
Position: Drug policy program pharmacist
Education/Post Graduation Training: PharmD, University of Wisconsin School of Pharmacy; PGY1 Froedtert Hospital
Organizational Involvement: UW Health smart pump oversight committee co- chair, UW Health medication use evaluation subcommittee member, UW Health pharmacy practice committee member, PSW member, PSW Medication Safety Collaborative member, REMEDI Pump Collaborative member
Current Projects/Initiatives: Development and maintenance of clinical guidelines, delegation protocols and other clinical tools, evaluation of formulary agents for use at UW Health, maintenance of UW Health smart pump libraries, analysis of adverse drug reactions at UW Health
Research Interests: Development of smart pump drug libraries to improve safety, analysis of smart pump utilization data to improve efficiency and encourage use of technology, creating alignment among various clinical tools at UW Health, addressing adverse drug reactions and reporting of information to improve pharmacovigilance, and finding ways to improve value of care provided
Daniel Kapp, PharmD, BCPS
Position: Clinical Pharmacist, Medication Use Strategy and Innovation; PGY2 Drug Information Program Coordinator
Education/Post-Graduate Training: PharmD from UW-Madison; PGY1 Pharmacy from Marshfield Clinic Health System (WI) and PGY2 Drug Information from Froedtert Health (WI)
Organizational Involvement: ASHP, PSW, ACCP, Vizient University Health-System Consortium Pharmacy Network
Current Projects/Initiatives: Medication value assessments for FDA approved products with Orphan Drug, Breakthrough Therapy, Accelerated Approval, or related designations
Research Interests: Clinical and economic value of approved drugs, biologics, and novel therapies; effective medication use systems for gene and cell therapies; US health care policy
Sara Shull, PharmD, MBA
Position: Drug Policy Program Analyst
Education/Post Graduation Training: PharmD, University of Nebraska College of Pharmacy; MBA University of Nebraska at Omaha; PGY 1 Nebraska Medical Center Organizational Involvement: UW Health Pharmacy and Therapeutics Committee administrator, UW Health Medication Use Evaluation subcommittee member, UW Health Anticoagulation subcommittee member, preceptor of Drug Policy Program APPE rotation, University of Wisconsin School of Pharmacy clinical faculty and
coordinator of Pharmacy Practice 570, “Drug Literature Evaluation”, ASHP member
and manuscript reviewer, PSW member and member of editorial board
Current Projects/Initiatives: drug shortage management, medication formulary management, development of and teaching drug literature evaluation class, medication use guidelines development and maintenance, development and maintenance of other drug policy tools, serving as preceptor to students and residents
Research Interests: medication value, advancing principles of evidence based medicine, development and integration of clinical practice guidelines, optimal management of drug shortages including maximizing manpower resources
Josh Vanderloo, PharmD, BCPS
Position: Clinical Pharmacist and Drug Policy Program Pharmacist
Education/Post Graduation Training: PharmD, University of Wisconsin School of Pharmacy; PGY1, Meriter Hospital
Organizational Involvement: UW Health Medication Use Evaluation Subcommittee, Chairperson, UW Health Immunization Programming and Planning Committee, Member, UW Health General Medicine Steering Committee, Member, UW Health Pharmacy Practice Committee, Member, PSW Member, PSW Manuscript Reviewer
Current Projects/Initiatives: Maintenance and development of guidelines,
delegation protocols, and clinical tools, Evaluation of new drug products for use at UW Health, Maintenance of UW Health Formulary information
Research Interests: Creation of clinical tools to help clinical pharmacists better care for patients while pursuing improved standardization and value of medication use, Leveraging electronic medical record to incorporate clinical decision support and best practices, Medication value derived from outcomes